Association between white matter impairment and cognitive dysfunction in patients with ischemic Moyamoya disease
Ziqi Liu(Shunyi Hospital of Beijing Traditional Chinese Medicine Hospital), Rong Wang(Yinchuan First People's Hospital), Zhe Yi(Capital Medical University), Yuan Li(Shanxi University), Ran Duan(Central South University), Shihao He(Chinese Academy of Medical Sciences & Peking Union Medical College), Chu Xiao(Peking University), Zongsheng Xu(Wuhan Municipal Engineering Design & Research Institute)
Cited by 30
Related Papers
Apremilast for Behçet’s Syndrome — A Phase 2, Placebo-Controlled Study
|New England Journal of Medicine|2015|241
Health risk in children to fluoride exposure in a typical endemic fluorosis area on Loess Plateau, north China, in the last decade
|Chemosphere|2019|77
Characteristics of cognitive impairment in adult asymptomatic moyamoya disease
|BMC Neurology|2020|39
Increased health threats from land use change caused by anthropogenic activity in an endemic fluorosis and arsenicosis area
|Environmental Pollution|2020|30